Table 2.

Characteristics of patients with EBV reactivation/PTLD after allogeneic SCT

Patients with EBV reactivation	48/79(60.7%)
Median time of reactivation (days-range)	55 (3–840)
Median EBV DNA copies/ml (range)	1.577.017,83 (408–60.000.000)
Number of reactivations	one 24/48 (50%) two 17/48 (35.4%) three 7/48 (14.6%)
PTLD	5/48 (10.4%)
Patients with peak in □-region	31/48 (64.6%)
Patients with Monoclonal Gammopathy	22/48 (45.8%)
Donor (sib/MUD)	28/20
Stem Cell Source	PB 43, CB 1, BM 4
Conditioning Regimen (abl/RIC)	21/27
ATG/Campath-1H	11/5
GvHD (acute vs chronic)	18 vs 7